取消
清空記錄
歷史記錄
清空記錄
歷史記錄
產(chǎn)品中心
生物活性
Tamoxifen (ICI 47699) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells[1][2][3]. Tamoxifen is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 μM and 1.8 μM, respectively[5]. Tamoxifen activates autophagy and induces apoptosis[4]. Tamoxifen also can induce gene knockout of CreER(T2) transgenic mouse[6
Estrogen receptor
HSP90
體外研究(In Vitro)
Tamoxifen (ICI 47699) shows strong inhibition of MCF-7 cells (EC50=1.41 μM) and to a lesser extent the T47D cells (EC50=2.5 μM) but does not affect the MDA-MB-231 cells
體內(nèi)研究(In Vivo)
Injection of pre-mutant mice with Tamoxifen (75 mg/kg; injected for 5 days at 6 weeks of age) results in the excision of the floxed exon and, thus, in a gene knockout
Animal Model:Aldh1l1-cre/ERT2 x Ai95 mice
Dosage:75 mg/kg
Administration:Injected for 5 days at 6 weeks of age
Result:Resulted in the excision of the floxed exon and a gene knockout.
中文名稱
他莫昔芬;三苯氧胺;它莫西芬
運(yùn)輸條件
Room temperature in continental US; may vary elsewhere
儲(chǔ)存方式
4°C, protect from light
*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
溶解性數(shù)據(jù)
DMSO : 62.5 mg/mL (168.23 mM; ultrasonic and warming and heat to 60°C)
Ethanol : 50 mg/mL (134.59 mM; Need ultrasonic)
濃度溶劑體積質(zhì)量 | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.6917 mL | 13.4586 mL | 26.9172 mL |
5 mM | 0.5383 mL | 2.6917 mL | 5.3834 mL |
10 mM | 0.2692 mL | 1.3459 mL | 2.6917 mL |
請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?6 個(gè)月內(nèi)使用,-20°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?1 個(gè)月內(nèi)使用。
請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥方式選擇適當(dāng)?shù)娜芙夥桨?。以下溶解方案都?qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑:
——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶
請(qǐng)依序添加每種溶劑: 30% PEG400 0.5% Tween80 5% Propanediol 64.5%H2O
Solubility: 5 mg/mL (13.46 mM); Suspended solution; Need ultrasonic
請(qǐng)依序添加每種溶劑: 10% DMSO 90% (20% SBE-β-CD in saline)
Solubility: 2.08 mg/mL (5.60 mM); Suspended solution; Need ultrasonic
請(qǐng)依序添加每種溶劑: 5% DMSO 95% (20% SBE-β-CD in saline)
Solubility: 0.83 mg/mL (2.23 mM); Suspended solution; Need ultrasonic
參考文獻(xiàn)
[1]. Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998 Nov 26;339(22):1609-18.
[6]. Feil S, et, al. Inducible Cre mice. Methods Mol Biol. 2009;530:343-63.
https://file.medchemexpress.cn/batch_PDF/HY-13757A/Tamoxifen-DataSheet-MedChemExpress.pdf
生物活性
Tamoxifen (ICI 47699) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells[1][2][3]. Tamoxifen is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 μM and 1.8 μM, respectively[5]. Tamoxifen activates autophagy and induces apoptosis[4]. Tamoxifen also can induce gene knockout of CreER(T2) transgenic mouse[6
Estrogen receptor
HSP90
體外研究(In Vitro)
Tamoxifen (ICI 47699) shows strong inhibition of MCF-7 cells (EC50=1.41 μM) and to a lesser extent the T47D cells (EC50=2.5 μM) but does not affect the MDA-MB-231 cells
體內(nèi)研究(In Vivo)
Injection of pre-mutant mice with Tamoxifen (75 mg/kg; injected for 5 days at 6 weeks of age) results in the excision of the floxed exon and, thus, in a gene knockout
Animal Model:Aldh1l1-cre/ERT2 x Ai95 mice
Dosage:75 mg/kg
Administration:Injected for 5 days at 6 weeks of age
Result:Resulted in the excision of the floxed exon and a gene knockout.
中文名稱
他莫昔芬;三苯氧胺;它莫西芬
運(yùn)輸條件
Room temperature in continental US; may vary elsewhere
儲(chǔ)存方式
4°C, protect from light
*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
溶解性數(shù)據(jù)
DMSO : 62.5 mg/mL (168.23 mM; ultrasonic and warming and heat to 60°C)
Ethanol : 50 mg/mL (134.59 mM; Need ultrasonic)
濃度溶劑體積質(zhì)量 | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.6917 mL | 13.4586 mL | 26.9172 mL |
5 mM | 0.5383 mL | 2.6917 mL | 5.3834 mL |
10 mM | 0.2692 mL | 1.3459 mL | 2.6917 mL |
請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?6 個(gè)月內(nèi)使用,-20°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?1 個(gè)月內(nèi)使用。
請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥方式選擇適當(dāng)?shù)娜芙夥桨浮R韵氯芙夥桨付颊?qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑:
——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶
請(qǐng)依序添加每種溶劑: 30% PEG400 0.5% Tween80 5% Propanediol 64.5%H2O
Solubility: 5 mg/mL (13.46 mM); Suspended solution; Need ultrasonic
請(qǐng)依序添加每種溶劑: 10% DMSO 90% (20% SBE-β-CD in saline)
Solubility: 2.08 mg/mL (5.60 mM); Suspended solution; Need ultrasonic
請(qǐng)依序添加每種溶劑: 5% DMSO 95% (20% SBE-β-CD in saline)
Solubility: 0.83 mg/mL (2.23 mM); Suspended solution; Need ultrasonic
參考文獻(xiàn)
[1]. Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998 Nov 26;339(22):1609-18.
[6]. Feil S, et, al. Inducible Cre mice. Methods Mol Biol. 2009;530:343-63.
https://file.medchemexpress.cn/batch_PDF/HY-13757A/Tamoxifen-DataSheet-MedChemExpress.pdf